Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, today announced the initiation of the Phase III clinical trial for Rentosertib, its ...
Globally recognized leader in early-phase oncology clinical development and experimental therapeuticsStrengthens strategic ...
Abstract: The automatic modulation recognition of communication signals plays an important role in military and civilian fields. Most of the existing recognition algorithms focus on a single ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results